Neuronetics

From Justapedia, unleashing the power of collective wisdom
Jump to navigation Jump to search
Neuronetics, Inc.
TypePublic
NasdaqSTIM
Russell 2000 Index component
Founded2003
HeadquartersMalvern, PA, United States
Key people
Keith J. Sullivan
(President and CEO)[1][2]

Stephen Furlong (CFO)[1] Andrew Macan
(General counsel)[1]

"NeuroStar Executive Team". Neuronetics.</ref>
Number of employees
167
As of March 31, 2018[3]
Websiteneurostar.com

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003,[3] that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

Neuronetics became "first and only Food and Drug Administration (FDA) approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device (FDA approval K061053)."[4]

They manufacture a transcranial magnetic stimulation device, NeuroStar.[5] The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil, against your head.[6][7]

References

External links